Issue navigation
Volume 13, Issue 4, August 2020
Editorial Comments
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes consensus conference
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 485–493, https://doi.org/10.1093/ckj/sfaa123
Hypoxia response and acute lung and kidney injury: possible implications for therapy of COVID-19
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 494–499, https://doi.org/10.1093/ckj/sfaa149
The growing pains of ifosfamide
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 500–503, https://doi.org/10.1093/ckj/sfaa017
Hypertensive nephropathy: a major roadblock hindering the advance of precision nephrology
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 504–509, https://doi.org/10.1093/ckj/sfaa162
Often forgotten, transport modality to dialysis may be life-saving
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 510–512, https://doi.org/10.1093/ckj/sfaa163
CKJ Reviews
Evidence in chronic kidney disease–mineral and bone disorder guidelines: is it time to treat or time to wait?
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 513–521, https://doi.org/10.1093/ckj/sfz187
Sweet dreams: therapeutic insights, targeting imaging and physiologic evidence linking sleep, melatonin and diabetic nephropathy
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 522–530, https://doi.org/10.1093/ckj/sfz198
Are endourological procedures for nephrolithiasis treatment associated with renal injury? A review of potential mechanisms and novel diagnostic indexes
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 531–541, https://doi.org/10.1093/ckj/sfaa020
Original Articles
The keys to control a COVID-19 outbreak in a haemodialysis unit
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 542–549, https://doi.org/10.1093/ckj/sfaa119
Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and meta-analysis
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 550–563, https://doi.org/10.1093/ckj/sfaa160
Prognosis and long-term outcomes of acute kidney injury due to snake envenomation
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 564–570, https://doi.org/10.1093/ckj/sfz055
Epicardial fat, cardiovascular risk factors and calcifications in patients with chronic kidney disease
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 571–579, https://doi.org/10.1093/ckj/sfz030
Measuring intradialyser transmembrane and hydrostatic pressures: pitfalls and relevance in haemodialysis and haemodiafiltration
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 580–586, https://doi.org/10.1093/ckj/sfz033
Creatinine clearance after cimetidine administration in a new short procedure: comparison with plasma and renal clearances of iohexol
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 587–596, https://doi.org/10.1093/ckj/sfz087
The longitudinal relationship between patient-reported outcomes and clinical characteristics among patients with focal segmental glomerulosclerosis in the Nephrotic Syndrome Study Network
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 597–606, https://doi.org/10.1093/ckj/sfz092
Association between urinary biomarkers and disease progression in adults with autosomal dominant polycystic kidney disease
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 607–612, https://doi.org/10.1093/ckj/sfz105
Anemia and iron deficiency among chronic kidney disease Stages 3–5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 613–624, https://doi.org/10.1093/ckj/sfz091
Incidence, risk factors and distribution of syphilis in the end-stage renal disease population in the USA
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 625–630, https://doi.org/10.1093/ckj/sfz090
Machine learning analysis of serum biomarkers for cardiovascular risk assessment in chronic kidney disease
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 631–639, https://doi.org/10.1093/ckj/sfz094
The effect of transportation modality to dialysis facilities on health-related quality of life among hemodialysis patients: results from the Japanese Dialysis Outcomes and Practice Pattern Study
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 640–646, https://doi.org/10.1093/ckj/sfz110
Vitamin K antagonist has a higher impact than heparin in preventing circuit clotting in chronic haemodialysis patients
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 647–653, https://doi.org/10.1093/ckj/sfz131
Clinical parameters predicting complications in native kidney biopsies
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 654–659, https://doi.org/10.1093/ckj/sfz132
Ifosfamide nephrotoxicity in adult patients
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 660–665, https://doi.org/10.1093/ckj/sfz183
Glucagon-like peptide-1 receptor and sarcoglycan delta genetic variants can affect cardiovascular risk in chronic kidney disease patients under hemodialysis
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 666–673, https://doi.org/10.1093/ckj/sfz182
Prospects for improved glomerular filtration rate estimation based on creatinine—results from a transnational multicentre study
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 674–683, https://doi.org/10.1093/ckj/sfaa039
Proteomic characterization of obesity-related nephropathy
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 684–692, https://doi.org/10.1093/ckj/sfaa016
The ERA-EDTA Registry Annual Report 2017: a summary
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 693–709, https://doi.org/10.1093/ckj/sfaa048
Exceptional Case
Biotin supplement interference with immunoassays for parathyroid hormone and 25-hydroxyvitamin D in a patient with metabolic bone disease on maintenance hemodialysis
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 710–712, https://doi.org/10.1093/ckj/sfz134
Letters to the Editor
Renal artery thrombosis induced by COVID-19
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Page 713, https://doi.org/10.1093/ckj/sfaa141
Recurrent hyperkalaemia management and use of renin–angiotensin–aldosterone system inhibitors: a European multi-national targeted chart review
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Pages 714–719, https://doi.org/10.1093/ckj/sfz129
Errata
Deficiency of complement factor H-related proteins and autoantibody-positive hemolytic uremic syndrome in an infant with combined partial deficiencies and autoantibodies to complement factor H and ADAMTS13
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Page 720, https://doi.org/10.1093/ckj/sfy028
Residual renal function in incremental haemodialysis
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Page 721, https://doi.org/10.1093/ckj/sfy116
The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study
Clinical Kidney Journal, Volume 13, Issue 4, August 2020, Page 722, https://doi.org/10.1093/ckj/sfz009
